New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
06:49 EDTSCMPSucampo to present data for lubiprostone
Sucampo Pharmaceuticals announced that clinical data for lubiprostone will be presented at the American Pain Society Conference in Tampa, Florida and Digestive Disease Week, or DDW, 2014 in Chicago, Illinois. Posters include: efficacy of lubiprostone for the treatment of opioid-induced constipation according to opioid class Poster 452; Lubiprostone for Treatment of Opioid-Induced Constipation: Analysis of Response by Opioid Class; a Pooled Analysis of Response to Lubiprostone in Patients With Opioid-Induced Constipation Receiving Non-Methadone Opioids Versus Methadone; nausea Reported by Patients Enrolled in Clinical Studies of Lubiprostone: Analysis of Well-Controlled and Long-Term, Open-Label Studies of Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Irritable Bowel Syndrome With Constipation; the CIC-2 chloride channel activator, lubiprostone, prevents ileal epithelial permeability alterations in a murine model of diarrhea-predominant irritable bowel syndrome.
News For SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
10:55 EDTSCMPSucampo founders' share registration removes overhang, says Cantor
Subscribe for More Information
08:44 EDTSCMPSucampo share sales to remove big overhang, says Roth Capital
Subscribe for More Information
January 16, 2015
16:46 EDTSCMPSucampo files to sell 25.68M shares of Class A common stock for holders
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use